Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

BACKGROUND: Graft-versus-host disease (GVHD) remains a major contributor to mortality and morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated recommendations suggest that rabbit antithymocyte globulin or anti-T-lymphocyte globulin (ATG) should be used for GVHD prophylaxis i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Hematol Oncol
Glavni autori: Brissot, Eolia, Labopin, Myriam, Moiseev, Ian, Cornelissen, J. J., Meijer, Ellen, Van Gorkom, Gwendolyn, Rovira, Montserrat, Ciceri, Fabio, Griskevicius, Laimonas, Blaise, Didier, Forcade, Edouard, Mistrik, Martin, Mielke, Stephan, Bulabois, Claude Eric, Niittyvuopio, Riitta, Deconinck, Eric, Ruggeri, Annalisa, Sanz, Jaime, Spyridonidis, Alexandros, Savani, Bipin, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333262/
https://ncbi.nlm.nih.gov/pubmed/32620146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00923-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items